ArticleCancers2019

Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with Glioma.

Pegah Mir Seyed Nazari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.